U.S. Cancer Cases, Deaths Continue to Drop

Report says lifestyle changes, better screening and treatment explain decrease

HealthDay SHARE

By Steven Reinberg
HealthDay Reporter

MONDAY, Dec. 7 (HealthDay News) -- Better screening, healthier living and new treatments have all continued to help cut the annual number of cancer cases and deaths in the United States, a new report says.

The findings showed that new cancer cases and deaths from cancer have declined significantly for both men and women and for most racial/ethnic populations.

These decreases were largely due to decreased incidence and death from lung, prostate and colon cancer among men and a drop in two of the three leading cancers in women (breast and colon cancers). New diagnoses for all types of cancer in the United States declined almost 1 percent per year from 1999 to 2006 and cancer deaths dropped 1.6 percent per year from 2001 to 2006.

The report, which appears in the Dec. 7 online edition of Cancer, was compiled from data by the American Cancer Society, the U.S. Centers for Disease Control and Prevention, the U.S. National Cancer Institute and the North American Association of Central Cancer Registries.

"For me, when I see the downturn in some cancers it says we can actually address the cancer burden through a variety of efforts," said report author Brenda K. Edwards, associate director of the Surveillance Research Program at the U.S. National Cancer Institute.

But the battle against cancer continues, she stressed. "We see the downturn in mortality, but we still have almost 1.5 million people with new cancer diagnoses in 2009. So, we still have a large number of people affected. For some of them, we have relatively effective treatments and for others not so."

Edwards noted that for the cancers that have seen the biggest decreases, such as breast and colon cancer, effective screening methods probably explain the downward trend, although there are still too few people who take advantage of them.

Cancer rates are still higher for men than for women, but men had the biggest declines in new cases and death, the report showed.

This year's report focused on trends in colorectal cancer. Colorectal cancer, the third most-diagnosed cancer in both men and women, is also the second-leading cause of cancer deaths in the United States. Overall, colon cancer rates are declining, but the decline is mostly among those over 65. Increasing numbers of cases in men and women under 50 is worrisome, the report noted.

Among both men and women, there were major declines in colorectal cancer cases from 1985 to 1995, minor increases from 1995 to 1998, and significant declines from 1998 to 2006. Since 1984, death rates also dropped, with accelerated rates of decline since 2002 for men and since 2001 for women.

In fact, from 1975 to 2000, cases of colorectal cancer fell 22 percent; 50 percent of which was most likely due to changes in lifestyle, and 50 percent to more people being screened.

In addition, deaths from colorectal cancer fell 26 percent during the same time; 9 percent of the drop came from lifestyle changes, 14 percent came from screening and 3 percent came from improved treatment, according to the report.

Going forward, if there were no changes in lifestyle, screening or treatment, there would be a 17 percent drop in colorectal cancer deaths from 2000 to 2020. However, if current trends remain the same, there will be a 36 percent drop in colorectal cancer deaths.

But, if more Americans adopted more healthy lifestyles, such as quitting smoking, and were screened for colon cancer and had access to optimal treatment (such as more effective chemotherapy), deaths from colon cancer could be reduced by 50 percent by 2020, the report predicted.

Other highlights from the report were that among men, cases of prostate, lung, oral cavity, stomach, brain, colon and rectum cancers have declined, but cases of kidney/renal, liver and esophageal cancer, along with leukemia, myeloma and melanoma, are increasing.

Among women, cases of breast, colorectal, uterine, ovarian, cervical and oral cavity cancers decreased, but cases of lung, thyroid, pancreatic, bladder and kidney cancers, along with non-Hodgkin lymphoma, melanoma and leukemia are on the rise.